A safety assessment of a fowlpox-vectored Mycoplasma gallisepticum vaccine in chickens

Poultry Science

Volumn 89, Issue 6, 2010, Pages 1301-1306

  Zhang, G Z ^a   Zhang, R ^a   Zhao, H L ^a,b   Wang, X T ^a   Zhang, S P ^a   Li, X J ^a   Qin, C Z ^a   Lv, C M ^a   Zhao, J X ^a   Zhou, J F ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b CEVA SANTÉ ANIMALE   (France)

Author keywords

Assessment; Fowlpox vector; Mycoplasma gallisepticum; Passage; Vaccine safety

Indexed keywords

FOWLPOX VIRUS; GALLUS GALLUS; MYCOPLASMA GALLISEPTICUM;

BACTERIAL VACCINE; RECOMBINANT VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CHICKEN; FOWLPOX VIRUS; GERMFREE ANIMAL; IMMUNOLOGY; MYCOPLASMA GALLISEPTICUM; MYCOPLASMOSIS;

ANIMALS; BACTERIAL VACCINES; CHICKENS; FOWLPOX VIRUS; MYCOPLASMA GALLISEPTICUM; MYCOPLASMA INFECTIONS; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, SYNTHETIC;

EID: 77954647999     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2009-00447     Document Type: Article

References (30)

1. Bayliss, C. D., R. W. Peters, J. K. Cook, R. L. Reece, K. Howes, M. M. Binns, and M. E. Boursnell. 1991. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch. Virol. 120: 193-205.
2. Bíró, J., J. Povazsán, L. Korösi, R. Glávits, L. Hufnagel, and L. Stipkovits. 2005. Safety and efficacy of Mycoplasma gallisepticum TS-11 vaccine for the protection of layer pullets against challenge with virulent M. gallisepticum R-strain. Avian Pathol. 34: 341-347.
3. Bostock, C. J. 1990. Viruses as vectors. Vet. Microbiol. 23: 55-71.
4. Boursnell, M. E., P. F. Green, J. I. Campbell, A. Deuter, R. W. Peters, F. M. Tomley, A. C. Samson, P. Chambers, P. T. Emmerson, and M. M. Binns. 1990. Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. J. Gen. Virol. 71: 621-628.
5. Boyle, D. B., M. A. Anderson, R. Amos, R. Voysey, and B. E. Coupar. 2004. Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules. Biotechniques 37: 104-106, 108-111.
6. Branton, S. L., B. D. Lott, J. W. Deaton, J. M. Hardin, and W. R. Maslin. 1988. F strain Mycoplasma gallisepticum vaccination of post-production-peak commercial Leghorns and its effect on egg and eggshell quality. Avian Dis. 32: 304-307.
7. Calvert, J. G., K. Nazerian, R. L. Witter, and N. Yanagida. 1993. Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens. J. Virol. 67: 3069-3076.
8. Chen, H. 2009. Avian influenza vaccination: The experience in China. Rev. Sci. Tech. 28: 267-274.
9. Davison, S., E. N. Gingerich, S. Casavant, and R. J. Eckroade. 2006. Evaluation of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/avian encephalomyelitis vaccine against ILT viral challenge. Avian Dis. 50: 50-54.
10. Heine, H. G., and D. B. Boyle. 1993. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Arch. Virol. 131: 277-292.
11. Jones, L., E. Tenorio, J. Gorham, and T. Yilma. 1997. Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus. Am. J. Vet. Res. 58: 590-593.
12. Lee, L. E., R. L. Witter, S. M. Reddy, P. Wu, N. Yanagida, and S. Yoshida. 2003. Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus. Avian Dis. 47: 549-558.
13. Levisohn, S., and S. H. Kleven. 2000. Avian mycoplasmosis (Mycoplasma gallisepticum). Rev. Sci. Tech. 19: 425-442.
14. Ley, D. H., J. M. McLaren, A. M. Miles, H. J. Barnes, S. H. Miller, and G. Franz. 1997. Transmissibility of live Mycoplasma gallisepticum vaccine strains ts-11 and 6/85 from vaccinated layer pullets to sentinel poultry. Avian Dis. 41: 187-194.
15. Mackett, M., G. L. Smith, and B. Moss. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49: 857-864.
16. Noormohammadi, A. H., J. E. Jones, G. Underwood, and K. G. Whithear. 2002. Poor systemic antibody response after vaccination of commercial broiler breeders with Mycoplasma gallisepticum vaccine ts-11 not associated with susceptibility to challenge. Avian Dis. 46: 623-628.
17. Polo, J. M., and T. W. Dubensky Jr. 2002. Virus-based vectors for human vaccine applications. Drug Discov. Today 7: 719-727.
18. Pozzi, E., V. Basavecchia, C. Zanotto, S. Pacchioni, Cde. G. Morghen, and A. Radaelli. 2009. Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins. J. Virol. Methods 158: 184-189.
19. Qiao, C., Y. Jiang, G. Tian, X. Wang, C. Li, X. Xin, H. Chen, and K. Yu. 2009. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus. Antiviral Res. 81: 234-238.
20. Robert-Guroff, M. 2007. Replicating and non-replicating viral vectors for vaccine development. Curr. Opin. Biotechnol. 18: 546-556.
21. Senne, D. A. 2003. Avian influenza in the Western Hemisphere including the Pacific Islands and Australia. Avian Dis. 47: 798-805.
22. Skinner, M. A., S. M. Laidlaw, I. Eldaghayes, P. Kaiser, and M. G. Cottingham. 2005. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry. Expert Rev. Vaccines 4: 63-76.
23. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. 2000. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18: 1088-1095.
24. Taylor, J., C. Edbauer, A. Rey-Senelonge, J. F. Bouquet, E. Norton, S. Goebel, P. Desmettre, and E. Paoletti. 1990. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 64: 1441-1450.
25. Villarreal, C. 2009. Avian influenza in Mexico. Rev. Sci. Tech. 28: 261-265.
26. Viscione, K. A., S. L. Branton, A. M. Vance, P. D. Gerard, S. K. Womack, and E. D. Peebles. 2009. Effects of 6/85-strain Mycoplasma gallisepticum vaccination alone at ten weeks of age or in conjunction with F-strain Mycoplasma gallisepticum inoculation overlays at twenty-two or forty-five weeks of age on the reproductive and digestive organs of commercial egg-laying hens. Poult. Sci. 88: 567-570.
27. Wang, X., W. M. Schnitzlein, D. N. Tripathy, T. Girshick, and M. I. Khan. 2002. Construction and immunogenicity studies of recombinant fowl poxvirus containing the S1 gene of Massachusetts 41 strain of infectious bronchitis virus. Avian Dis. 46: 831-838.
28. Whithear, K. G. 1996. Control of avian mycoplasmoses by vaccination. Rev. Sci. Tech. 15: 1527-1553.
29. Whithear, K. G., Soeripto, K. E. Harrigan, and E. Ghiocas. 1990. Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine. Aust. Vet. J. 67: 168-174.
30. Yamanouchi, K., T. Barrett, and C. Kai. 1998. New approaches to the development of virus vaccines for veterinary use. Rev. Sci. Tech. 17: 641-653.